How close you live to a golf course impacts your chances of getting Parkinson's, study shows
Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email
People who live within one mile of a golf course double their risk of developing Parkinson's disease, new research has suggested.
Chemicals used to maintain fairways and greens in perfect shape may be causing the disease by leaking into water sources or escaping into the atmosphere, according to US researchers.
The scientists from the Barrow Neurological Institute in Arizona examined health data from people living near 139 golf courses in southern Minnesota and western Wisconsin.
They found that people who lived within a mile of a golf course had a 126 per cent higher chance of getting Parkinson's disease than people who lived more than six miles away.
The study also discovered that the likelihood of developing Parkinson's disease decreased by 13 per cent for every mile away from the greens, indicating a linear association between the two.
Parkinson's disease is the world's second most common neurodegenerative disorder, behind Alzheimer's disease.
It is a degenerative neurological condition, which means that over time the brain of an individual living with the disease becomes more damaged, according to the NHS. Parkinson's disease is the world's second most common neurodegenerative disorder, behind Alzheimer's disease (Getty/iStock)
Around 145,000 people in the UK are affected by Parkinson's disease, according to charity Parkinson's UK.
Writing in the journal Jama Network Open, Dr Brittany Krzyzanowski said: 'These findings suggest that pesticides applied to golf courses may play a role in the incidence of Parkinson's disease for nearby residents.
'Public health policies to reduce the risk of groundwater contamination and airborne exposure from pesticides on golf courses may help reduce the risk of Parkinson's disease in nearby neighbourhoods.'
The research also found that people who get their drinking water from water service areas with a golf course had nearly double the odds of Parkinson's compared to those getting drinking water from water service areas without a golf course.
Pesticides such as paraquat and rotenone have been shown to induce Parkinson-like neurodegeneration, the study said.
In the UK and the EU, the use of pesticides is strictly controlled, and paraquat is banned due to concerns about their wider health and environmental impacts, Dr Katherine Fletcher, Research Lead at Parkinson's UK, said. The risk for most people in the UK is therefore 'extremely low', she said. Around 145,000 people in the UK are affected by Parkinson's disease, according to charity Parkinson's UK. (Getty/iStock)
The US researchers suggested public health policies aimed at reducing the risk of groundwater contamination and airborne exposure from pesticides on golf courses may help reduce the risk of the disease in nearby neighbourhoods.
According to the NHS, symptoms of Parkinson's usually develop after the age of 50. However, for one in 20 people affected by the disease, symptoms may appear when they're under the age of 40.
Dr Fletcher added: 'Parkinson's is complex. The causes of the condition are unclear and are likely to involve both genetic and environmental factors. Many studies have investigated whether pesticides increase the risk of developing Parkinson's in different populations around the world.
'The results have been varied, but overall suggest that exposure to pesticides may increase the risk of the condition. However, the evidence is not strong enough to show that pesticide exposure directly causes Parkinson's.
'This study supports the association between pesticides and Parkinson's. However, it's quite reductive and doesn't take into account how someone might have been exposed to pesticides at their workplace or whether they have a genetic link to the condition.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Patients may be seen by any dental surgery
Patients could be moved around dental surgeries under proposed changes to the system. Instead of having a regular surgery, the changes could see people offered treatment at any practice within their health board area, with check-ups for those with healthy teeth pushed to every 18 to 24 months. The Welsh government said the proposals would improve access to dental services, particularly for those most in need. But the British Dental Association (BDA) said the opposite could happen and more patients may be forced to go private. The biggest change would see all patients over 18 placed onto a central waiting list, called the Dental Access Portal (DAP). They would then be allocated a surgery, which could be anywhere within the health board area. If they need treatment, they would remain with that surgery until it is complete and beyond, if they needed close monitoring. If or when teeth are healthy, patients would be returned to the central portal and would be recalled for a check-up in 18 to 24 months wherever there is space. Children would be assessed under the plans but stay at the first surgery they are allocated. Some charges for patients would also change - with check-ups going up from £20 to £24.75 but a single crown going down from £260 to £239.15. 'There could be no NHS dentists in two years' Welsh dentistry 'no example' to England Family unable to see a dentist in four years Health Minister Jeremy Miles said the plans would benefit everyone. "It will make NHS dentistry more attractive to dentists and that is good for patients," he said. "Actually, what we want to make sure is that patients do look after their own oral health but when they do need to see a dentist they will be able to access one which is the critical thing." Jody Pegler, 46, from Pontllanfraith, Caerphilly county, who has been with his dentist in Newbridge for more than 30 years, said: "I have been coming here since I was a child. "It's nice to see the same person on a regular basis." Mr Pegler, who has cerebral palsy and uses a wheelchair, said his family members needing to visit different surgeries could be problematic. "My wife, my child and myself could potentially be attending different practices," he said. "It's difficult to get out and to go anywhere really and if we have to go to different practices it would be impossible. "This dentist's in particular have made a big effort to make sure the practice is wheelchair accessible for me - that means a lot." Jody's dentist is Dr Harj Singhrao, owner of Newbridge Dental Care, who believes the potential breakdown in continued care will be "devastating". "If families can't be seen at the same practice, if people are punished then to join a waiting list because they have looked after their mouth, then where are they going to go? Because we know hospital waiting lists don't work," he said. The proposals are now part of a public consultation, open until 19 June, and in Cardiff people gave a mixed response to the plans when asked by BBC Wales. Robyn Weldon, 21, said: "I've been going to my dentist since I was probably six so I guess that would be a bit sad if I can't go to him. "I would say too that things haven't been going very well for the NHS so maybe this could be a good start to kind of make things easier for them and for us." Paul McCarthy, 77, said he was unaware of the changes. "I wouldn't be very happy about it either," he said. "I've been coming here for over 30 years and I'm used to coming here so I wouldn't like that at all." Justin Rees, 52, from Barry, Vale of Glamorgan, thought the new portal idea could be positive. "It's good because one, there are no appointments at the moment. "Two, it'll remind people that they need to have their teeth checked because you're busy all day and there's things that you let go," he said. In relation to how people currently access services, the consultation document says "contrary to popular belief" patients are not actually registered with a practice once their treatment ends, adding "for those who clinically require regular access, or an urgent need arises, nothing really changes". On check-ups, it says there is "false narrative" that six-monthly check-ups are necessary for everyone and that by giving people with healthy teeth a check-up less often, it will open up access for others. NICE guidelines say intervals between check-ups "should be determined specifically for each patient" and the longest interval for adults should be 18-24 months. But Dr Lauren Harrhy from the BDA said she was concerned that people may end up waiting much longer, with "most people" benefiting from regular checks. Dr Harrhy, who runs a practice in Pontypool, Torfaen, said: "If we are always having patients into the practice who need lots of work done and they are not able to be put back into the central database, there is a saturation point and at which point, access into dental practices will cease. "Our main concerns are we will have an overall reduction in the continuity of care... and we may find that dentists leave NHS dentistry which has been a trend over recent years anyway." Dentists also say the proposals offer no extra money to fund the changes. But Miles said investment in dentistry had increased year on year. "This isn't a contract we have drawn up from thin air, it is based on years worth of work, it's 13 months of negotiations with the BDA itself," he said. "No contract gives everybody exactly what they want but I am absolutely confident that for everybody - for patients, for dentists, for the NHS, for the government - this is a step forward." British Dental Association Why can't I find an NHS dentist in Wales? Fees will see more people pull teeth out - dentist Patient, 73, has 100-mile round trip for dentist
American Military News
3 hours ago
- American Military News
Musk walks back threat to decommission SpaceX Dragon spacecraft
Elon Musk seemingly backed down from a threat to decommission SpaceX's Dragon spacecraft that ferries cargo and people to the International Space Station for the U.S., made during an escalation of a spat between the billionaire and President Donald Trump. SpaceX's Dragon spacecraft is the company's primary vehicle for sending astronauts and cargo to orbit. The company has billions of dollars in contracts with NASA to send the agency's astronauts on periodic trips to and from the ISS, which helps the space agency to maintain an uninterrupted presence at the space station until its retirement by the end of 2030. Musk initially pledged to decommission the spacecraft after Trump's threat to pull Musk's governmental contracts, which was prompted by Musk's near-incessant bashing of the president's tax bill on X, his social media service. However, just hours later, he responded to a post suggesting he take a step back and cool off for a couple of days, replying 'Good advice. OK, we won't decommission Dragon.' It's unclear what exactly Musk initially meant by 'decommissioning' Dragon. SpaceX also uses its Dragon spacecraft for commercial missions, separate from the ones it performs for NASA. The company has flown six private astronaut missions on Dragon, either to fly freely in orbit or visit the International Space Station. SpaceX is scheduled to launch another private astronaut mission on Dragon as soon as June 10, in partnership with Axiom Space, sending four civilians to the ISS. NASA will 'continue to execute upon the President's vision' and work with its industry partners, agency spokesperson Bethany Stevens said in a post on X. An abrupt end to SpaceX's Dragon would leave NASA in a significant bind regarding its space station program. The vehicle is the only operational U.S. option for sending astronauts to the space station, though the agency does also rely on Russia's Soyuz spacecraft to launch NASA astronauts periodically. It's also one of the main options for keeping the space station stocked with food and supplies. NASA potentially has another U.S. option for sending crew to the space station in Boeing's Starliner. However, the vehicle is still not certified for carrying astronauts, after suffering a botched test flight in 2024 that left two astronauts on the ISS for months longer than planned. Because of engine issues with Starliner, NASA tasked SpaceX with bringing home the astronauts on a Dragon craft. SpaceX is also under contract with NASA for creating a Dragon-like vehicle that will be responsible for guiding the ISS out of orbit. It's unclear where those plans currently stand. ___ © 2025 Bloomberg L.P. Distributed by Tribune Content Agency, LLC.
Yahoo
3 hours ago
- Yahoo
Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory
We came across a bullish thesis on Alpha Cognition Inc. Common Stock (ACOG) by anygal on r/investing on Reddit. In this article, we will summarize the bulls' thesis on ACOG. Alpha Cognition Inc. Common Stock (ACOG)'s share was trading at $9.33 as of 30th May. ACOG's forward P/E was 26.88 according to Yahoo Finance. A chemist in a laboratory analyzing data from the various therapeutic tests conducted. Alpha Cognition Inc. (NASDAQ: ACOG) represents a potentially overlooked opportunity in the Alzheimer's treatment space, having recently launched its oral drug, Zunveyl, at the end of March. With a current market cap of $150 million and $45 million in cash, the company is targeting the underserved segment of the Alzheimer's population—specifically, the 50% of patients in long-term care (LTC) not taking any current medications due to severe side effects. Unlike other galantamine-based drugs, Zunveyl significantly slows disease progression and improves short-term memory with a markedly better safety profile—only one serious side-effect case was reported in its Phase 3 trials, versus a 50% rate seen in traditional options. The drug's Medicare coverage further eases affordability, lowering monthly out-of-pocket costs to $30–$190. Initial demand appears promising, with nearly 500 patients starting treatment in the first two weeks of launch. Even a modest 1% market penetration into the LTC segment could yield $135 million in annual revenue, with $67.5 million in net income assuming 50% margins. A 5% penetration would put net income at $675 million, dwarfing the current valuation. Alpha Cognition has also secured a distribution deal with a major Chinese pharmaceutical firm, creating a royalty-based revenue stream in Asia. While the upside is substantial, key risks remain—most notably, the emergence of unforeseen serious side effects post-launch, which could lead to FDA scrutiny or suspension of sales. Still, the market's underreaction and the company's positioning as a safer, effective alternative in a high-need space make ACOG a high-upside, high-conviction bet for risk-tolerant investors. Previously, we have covered ACOG in March 2025 wherein we summarized a by BullishDoctor on Twitter. The user highlighted that Alpha Cognition Inc.'s drug ZUNVEYL addressed the major side effects of existing Alzheimer's treatments, making it highly tolerable and poised for adoption in long-term care facilities, a $2 billion market. The company was pre-revenue but launched in March 2025 with strong physician support, a nearly complete sales force, and promising catalysts like a Phase 4 study and sublingual formulation, projecting breakeven within three years. Since our last coverage, the stock is up 61% as of 30th May. Alpha Cognition Inc. Common Stock (ACOG) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 8 hedge fund portfolios held ACOG at the end of the first quarter which was 10 in the previous quarter. While we acknowledge the potential of ACOG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
